Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis

Journal of Medical Virology

Volumn 56, Issue 1, 1998, Pages 79-84

  Marsden, H S ^a   MacAulay, K ^a   Murray, J ^a   Smith, I W ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Epitope mapping; gG2; Glycoprotein G; HSV 2; Immunodominant epitope; Serodiagnosis

Indexed keywords

THROMBOSPONDIN;

ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; OPEN READING FRAME; PROTEIN SYNTHESIS; SERODIAGNOSIS; TECHNIQUE;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNODOMINANT EPITOPES; VIRAL ENVELOPE PROTEINS;

DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2;

EID: 0031822901     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199809)56:1<79::AID-JMV13>3.0.CO;2-R     Document Type: Article

References (30)

1. Ackerman M, Longnecker R, Roizman B, Periera L (1986): Identification, properties and gene location of a novel glycoprotein specified by herpes simplex virus type 1. Virology 150:207-220.
2. Ashley RL, Militoni U, Lee F, Nahmias A, Corey L (1988): Comparison of Western blot (Immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus type 1 and 2 in human sera. Journal of Clinical Microbiology 26:662-667.
3. Atherton E, Sheppard RC (1989): "Solid-Phase Peptide Synthesis: A Practical Approach." New York: Oxford University Press.
4. Balachandran N, Hutt-Fletcher LM (1985): Synthesis and processing of glycoprotein gG of herpes simplex virus type 2. Journal of Virology 54:825-832.
5. Bhattacherjee L, Prescott LE, Pike I, Rodgers B, Bell H, El-Zayadi AR, Kew MC, Conradie J, Lin CK, Marsden HS, Safeed AA, Parker D, Yap PL, Simmonds P (1995): Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5, and 6. Journal of General Virology 76:1737-1748.
6. Boucher FD, Yasukawa LL, Kerns K, Kastelein M, Arvin AM, Prober CG (1993): Detection of antibodies to herpes simplex virus type 2 with a mammalian cell line expressing glycoprotein gG2. Clinical Diagnosis in Virology 1:29-38.
7. Frame MC, Marsden HS, McGeoch DJ (1986): Novel herpes simplex virus type 1 glycoproteins identified by antiserum against a synthetic oligopeptide from the predicted product of gene US4. Journal of General Virology 67:745-751.
8. Hashido M, Lee FK, Inouye S, Kawana T (1987): Detection of herpes simplex virus type-specific antibodies by an enzyme-linked immunosabsorbent assay based on glycoprotein G. Journal of Medical Virology 53:319-323.
9. Ho DWT, Field PR, Sjögren-Jansson E, Jeansson S, Cunningham AL (1992): Indirect ELISA for the detection of HSV-2-specific IgG and IgM antibodies with glycoprotein G (gG2). Journal of Virological Methods 36:249-264.
10. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks SA, Snowden CB (1989): A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. New England Journal of Medicine 321:7-12.
11. Kakkanas A, Papadogeorgaki H, Manservigi R, Miriagou V, Georgopoulou U, Mavromara P (1995): Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays. Intervirology 38:346-351.
12. Lee FK, Coleman M, Pereira L, Bailey PD, Tatsuno M, Nahmais AJ (1985): Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. Journal of Clinical Microbiology 22:641-644.
13. Marsden HS, Stow ND, Preston VG, Timbury MC, Wilkie NM (1978): Physical mapping of herpes simplex virus-induced polypeptides. Journal of Virology 28:624-642.
14. Marsden HS, Buckmaster A, Palfreyman JW, Hope RG, Minson AC (1984): Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. Journal of Virology 50:547-554.
15. Marsden HS, Owsianka AM, Graham S, McLean GW, Robertson CA, Suhak-Sharpe JH (1992): Advantages of branched peptides in serodiagnosis: Detection of HIV-specific antibodies and the use of glycine spacers to increase sensitivity. Journal of Immunological Methods 147:65-72.
16. McGeoch DJ, Dolan A, Donald S, Rixon FJ (1985): Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. Journal of Molecular Biology 181:1-13.
17. McGeoch DJ, Moss HWM, McNab D, Frame MC (1987): DNA sequence and genetic content of the HindIIIl region in the short unique component of the herpes simplex virus type 2 genome: Identification of the gene encoding glycoprotein G, and evolutionary comparisons. Journal of General Virology 68:19-38.
18. McLean GW, Owsianka AM, Subak-Sharpe JH, Marsden HS (1991): Generation of antipeptide and antiprotein sera: Effect of peptide presentation on immunogenicity. Journal of Immunological Methods 137:149-157.
19. Olofsson S, Lundstrom M, Marsden H, Jeansson S, Vahlne A (1986): Characterization of a herpes simplex virus type 2-specified glycoprotein with affinity for N-acetylgalactosamine-specific lectins and its identification as g92K or gG. Journal of General Virology 67:737-744.
20. Parkes DL, Smith CM, Rose JM, Brandis J, Coates SR (1991): Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G. Journal of Clinical Microbiology 29:778-781.
21. Roizman B, Norrild B, Chan C, Pereira L (1984): Identification and preliminary mapping with monoclonal antibodies of a herpes sim-plex virus type 2 glycoprotein lacking a known type-1 counterpart. Virology 133:242-247.
22. Ross JDC, Smith IW, Elton RA (1993): The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourinary Medicine 69:381-383.
23. Safrin S, Arvin A, Mills J, Ashley R (1992): Comparison of the Western Immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. Journal of Clinical Microbiology 30:1312-1314.
24. Sanchez-Martinez D, Schmid DS, Whittington W, Brown D, Reeves WC, Chatterjee S, Whitley RJ, Pellett PE (1991): Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. Journal of Infectious Diseases 164:1196-1199.
25. Simmonds P, Rose K, Graham S, McOmish F, Dow BC, Follett EAC, Yap PL, Chan S-W, Marsden H (1993): Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus: Use of type-specific peptides to serologically differentiate infection with HCV types 1, 2, and 3. Journal of Clinical Microbiology 31:1493-1503.
26. Slomka MJ, Ashley RL, Cowan FM, Cross A, Brown DWG (1995): Monoclonal antibody blocking tests for the detection of HSV-1-and HSV-2-specific humoral responses: Comparison with Western blot assay. Journal of Virological Methods 55:27-35.
27. Svennerholm B, Olofsson S, Vahlne A, Lycke E (1984): Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. Journal of Clinical Microbiology 19:235-239.
28. Tam JP (1988): Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system. Proceedings of the National Academy of Sciences U.S.A. 85:5409-5413.
29. Whitley RJ (1996): Herpes simplex viruses. In Fields BN, Knipe DM, Howley PM (eds): "Fields Virology," 3rd edit. Lippincott-Raven, pp 2297-2342.
30. WHO Workshop (1995): Epidemiology of herpes simplex virus infections and surveillance of other sexually transmitted diseases in Europe. Copenhagen, Denmark.